News & Updates
Filter by Specialty:

Blood-based CRC screening platform delivers promising performance
An investigational blood-based test performs satisfactorily for the early detection of colorectal cancer (CRC), having met all prespecified primary endpoints in the large PREEMPT CRC trial.
Blood-based CRC screening platform delivers promising performance
13 Jun 2024
Fatigue, pain weigh down people with fibromyalgia
Several symptoms of individuals with fibromyalgia (FM), including fatigue and sleep disturbance, have significant impacts on their daily life, and the prevalence of such symptoms may vary depending on demographic categories and disability status, according to a study.
Fatigue, pain weigh down people with fibromyalgia
13 Jun 2024
Intense exercise safe for men with metastatic prostate cancer
Patients with metastatic prostate cancer can safely engage in intense exercise training to improve survival outcomes, suggests a study presented at AACR 2024.
Intense exercise safe for men with metastatic prostate cancer
13 Jun 2024
Telemedicine works well in acute coronary syndrome
Remote assessment appears effective in reducing hospital readmission, emergency department (ED) visits, unplanned revascularization, and patient-reported symptoms following an acute coronary syndrome (ACS), reports a study.
Telemedicine works well in acute coronary syndrome
13 Jun 2024
Are fertility treatments safe in young breast cancer survivors who have high-risk genes?
In young breast cancer survivors harbouring BRCA1/2 pathogenic variants, using assisted reproductive techniques (ART) to conceive did not appear to negatively affect maternal or pregnancy outcomes, findings from an international retrospective cohort study suggest.
Are fertility treatments safe in young breast cancer survivors who have high-risk genes?
13 Jun 2024
Statins may protect against primary sclerosing cholangitis in IBD patients
Patients with inflammatory bowel disease (IBD) who use statins appear to have a substantially reduced risk of primary sclerosing cholangitis (PSC), as shown in a retrospective study.
Statins may protect against primary sclerosing cholangitis in IBD patients
12 Jun 2024
Olaparib extends survival in gBRCA-mutated breast cancer
The intermittent 48-h “gap” schedule of olaparib in combination with carboplatin/paclitaxel and anthracycline chemotherapy provides substantial survival benefits in patients with germline BRCA-mutated breast cancer (gBRCA) regardless of their pathological complete response (pCR) status, results of the PARTNER trial have shown.